Elite Pharmaceuticals Inc (ELTP): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2024-03-31, while the company's latest annual report covers the year ended 2026-03-31. Its later filings do not report this line under the concept TickerFacts maps.
$7.11M
As of 2024-03-31
+30.6%
3-year compound annual growth
+25.6%
5-year compound annual growth
+0.2%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2024-03-31 | $7.11M | -9.3% | 2024-07-01, Balance as of period end |
| 2023-03-31 | $7.83M | -8.2% | 2024-07-01, Balance as of period end |
| 2022-03-31 | $8.54M | +167.3% | 2023-06-29, Balance as of period end |
| 2021-03-31 | $3.19M | +182.1% | 2022-06-29, Balance as of period end |
| 2020-03-31 | $1.13M | -50.3% | 2021-06-14, Balance as of period end |
| 2019-03-31 | $2.28M | -68.3% | 2020-06-29, Balance as of period end |
| 2018-03-31 | $7.18M | -32.2% | 2019-06-21, Balance as of period end |
| 2017-03-31 | $10.59M | -8.0% | 2018-06-14, Balance as of period end |
| 2016-03-31 | $11.51M | +54.2% | 2018-06-14, Balance as of period end |
| 2015-03-31 | $7.46M | +7.5% | 2017-06-14, Balance as of period end |
| 2014-03-31 | $6.94M | n/m | 2016-06-15, Balance as of period end |
| 2013-03-31 | $369.0K | -44.8% | 2014-06-30, Balance as of period end |
| 2012-03-31 | $668.4K | -63.4% | 2013-06-21, Balance as of period end |
| 2011-03-31 | $1.83M | n/a | 2012-06-29, Balance as of period end |